Nanoco Technologies is a UK-based company specializing in the research, development, and manufacturing of cadmium-free quantum dots and semiconductor nanoparticles. Their products, including CFQD® quantum dot films and nanoparticles, have applications in displays, lighting, solar energy, and biological imaging. Nanoco’s proprietary ‘molecular seeding’ process enables the scalable production of quantum dots with precise dimensions, ensuring consistent quality. The company holds a robust intellectual property portfolio with 375 patents granted and pending, covering quantum dot chemistry, manufacturing processes, and various applications. Nanoco has established partnerships with major industry players, including a global licensing agreement with Dow for the sale, marketing, and manufacture of cadmium-free quantum dots for electronic displays. Financially, Nanoco has demonstrated growth, with revenues increasing from £2.5 million in 2022 to £5.6 million in 2023. The company is listed on the London Stock Exchange under the ticker symbol NANO.
For investors, Nanoco presents a compelling opportunity due to its leadership in nanomaterials technology, addressing diverse and rapidly growing markets. The company’s experienced management and technical team have built significant customer traction and developed a large, defensible intellectual property portfolio. Nanoco’s platform technology is customisable for various applications, from sensing to display, and its unique production process allows for scalable, controllable manufacturing. The company has a significant manufacturing scale, with a revenue capacity of £130 million, and continues to invest in research and development, with £1.8 million invested in 2022.
